Optimizing Patient Outcome in Intracranial Tumor Surgery: a Detailed Prospective Study of Adverse Events and Mortality Reduction Strategies in Neurosurgery

Overview

Journal Acta Neurochir (Wien)

Specialty Neurosurgery

Date 2024 Mar 8

PMID 38457057

Authors

Pavlina Lenga

Helena Kleineidam

Andreas Unterberg

Philip Dao Trong

Affiliations

Soon will be listed here.

Abstract

Introduction: Brain tumor surgery represents a critical and high-risk area within the field of neurosurgery. Our study aims to offer a comprehensive analysis of adverse events (AEs) from a prospectively maintained database at a leading neurosurgical tertiary center, with a specific focus on different types of tumor entities.

Methods: From January 2022 to September 2023, our study focused on adult patients, who underwent surgery for intracranial tumors. Each patient in this demographic was thoroughly assessed for adverse events (AEs) by their attending physicians at discharge. An AE was defined as any event occurring within the first 30 days post-surgery.

Results: A total of 1173 patients with an average age of 57.4 ± 15.3 years underwent surgical procedures. The majority of these surgeries were elective, accounting for 93.4% (1095 out of 1173), while emergency surgeries constituted 13.9% (163 out of 1173). The incidence of surgery-related AEs was relatively low at 12.7%. The most common surgical indications were meningioma and glioma pathologies, representing 31.1% and 28.2% of cases, respectively. Dural leaks occurred in 1.5% of the cases. Postoperative hemorrhage was a significant complication, especially among glioma patients, with ten experiencing postoperative hemorrhage and eight requiring revision surgery. The overall mortality rate stood at 0.8%, corresponding to five patient deaths. Causes of death included massive postoperative bleeding in one patient, pulmonary embolism in two patients, and tumor progression in two others.

Conclusions: Surgical interventions for intracranial neoplasms are inherently associated with a significant risk of adverse events. However, our study's findings reveal a notably low mortality rate within our patient cohort. This suggests that thorough documentation of AEs, coupled with proactive intervention strategies in neurosurgical practices, can substantially enhance patient outcomes.

References

Zegers M, de Bruijne M, de Keizer B, Merten H, Groenewegen P, van der Wal G . The incidence, root-causes, and outcomes of adverse events in surgical units: implication for potential prevention strategies. Patient Saf Surg. 2011; 5:13. PMC: 3127749. DOI: 10.1186/1754-9493-5-13. View

Terrapon A, Zattra C, Voglis S, Velz J, Vasella F, Akeret K . Adverse Events in Neurosurgery: The Novel Therapy-Disability-Neurology Grade. Neurosurgery. 2021; 89(2):236-245. DOI: 10.1093/neuros/nyab121. View

Senders J, Muskens I, Cote D, Goldhaber N, Dawood H, Gormley W . Thirty-Day Outcomes After Craniotomy for Primary Malignant Brain Tumors: A National Surgical Quality Improvement Program Analysis. Neurosurgery. 2018; 83(6):1249-1259. DOI: 10.1093/neuros/nyy001. View

Donoho D, Wen T, Babadjouni R, Schwartzman W, Buchanan I, Cen S . Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data. J Neurooncol. 2017; 136(1):87-94. PMC: 7441072. DOI: 10.1007/s11060-017-2625-3. View

Neumann J, Schmidt S, Nohman A, Jakobs M, Unterberg A . Routine ICU admission after brain tumor surgery: retrospective validation and critical appraisal of two prediction scores. Acta Neurochir (Wien). 2023; 165(6):1655-1664. PMC: 10147995. DOI: 10.1007/s00701-023-05592-9. View

Xue H, Sveinsson O, Bartek Jr J, Forander P, Skyrman S, Kihlstrom L . Long-term control and predictors of seizures in intracranial meningioma surgery: a population-based study. Acta Neurochir (Wien). 2018; 160(3):589-596. DOI: 10.1007/s00701-017-3434-3. View

Tang K, Feng X, XiaodongYuan , Li Y, XinyueChen . Volumetric comparative analysis of anatomy through far-lateral approach: surgical space and exposed tissues. Chin Neurosurg J. 2022; 8(1):1. PMC: 8744288. DOI: 10.1186/s41016-021-00268-8. View

Lenga P, Dao Trong P, Papakonstantinou V, Kiening K, Unterberg A, Ishak B . Adverse events in spine surgery: a prospective analysis at a large tertiary center in Germany. Acta Neurochir (Wien). 2023; 165(9):2689-2697. PMC: 10477100. DOI: 10.1007/s00701-023-05752-x. View

Dimick J, Chen S, Taheri P, Henderson W, Khuri S, Campbell Jr D . Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004; 199(4):531-7. DOI: 10.1016/j.jamcollsurg.2004.05.276. View

Dao Trong P, Olivares A, El Damaty A, Unterberg A . Adverse events in neurosurgery: a comprehensive single-center analysis of a prospectively compiled database. Acta Neurochir (Wien). 2023; 165(3):585-593. PMC: 10006024. DOI: 10.1007/s00701-022-05462-w. View

10.

Grundy P, Weidmann C, Bernstein M . Day-case neurosurgery for brain tumours: the early United Kingdom experience. Br J Neurosurg. 2008; 22(3):360-7. DOI: 10.1080/02688690801961858. View

11.

Landriel Ibanez F, Hem S, Ajler P, Vecchi E, Ciraolo C, Baccanelli M . A new classification of complications in neurosurgery. World Neurosurg. 2011; 75(5-6):709-15. DOI: 10.1016/j.wneu.2010.11.010. View

12.

Bhat A, Wani M, Kirmani A . Infra-tentorial brain tumor subtypes in children and adults-surgical outcome in an ethnic population with a single regional tertiary center. Chin Neurosurg J. 2022; 8(1):10. PMC: 9066939. DOI: 10.1186/s41016-022-00275-3. View

13.

Vecchio T, Corell A, Buvarp D, Ryden I, Smits A, Jakola A . Classification of Adverse Events Following Surgery in Patients With Diffuse Lower-Grade Gliomas. Front Oncol. 2022; 11:792878. PMC: 8724913. DOI: 10.3389/fonc.2021.792878. View

14.

Delgado-Fernandez J, Garcia-Pallero M, Blasco G, Penanes J, Gil-Simoes R, Pulido P . Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival. World Neurosurg. 2017; 108:610-617. DOI: 10.1016/j.wneu.2017.09.062. View

15.

Dasenbrock H, Yan S, Smith T, Valdes P, Gormley W, Claus E . Readmission After Craniotomy for Tumor: A National Surgical Quality Improvement Program Analysis. Neurosurgery. 2017; 80(4):551-562. DOI: 10.1093/neuros/nyw062. View

16.

Vasella F, Velz J, Neidert M, Henzi S, Sarnthein J, Krayenbuhl N . Safety of resident training in the microsurgical resection of intracranial tumors: Data from a prospective registry of complications and outcome. Sci Rep. 2019; 9(1):954. PMC: 6353994. DOI: 10.1038/s41598-018-37533-3. View

17.

Jenkins F, Vasella F, Padevit L, Mutschler V, Akeret K, Velz J . Preoperative risk factors associated with new focal neurological deficit and other major adverse events in first-time intracranial meningioma neurosurgery. Acta Neurochir (Wien). 2021; 163(10):2871-2879. PMC: 8437836. DOI: 10.1007/s00701-021-04897-x. View

18.

Houkin K, Baba T, Minamida Y, Nonaka T, Koyanagi I, Iiboshi S . Quantitative analysis of adverse events in neurosurgery. Neurosurgery. 2009; 65(3):587-94. DOI: 10.1227/01.NEU.0000350860.59902.68. View

19.

Schipmann S, Brix T, Varghese J, Warneke N, Schwake M, Brokinkel B . Adverse events in brain tumor surgery: incidence, type, and impact on current quality metrics. Acta Neurochir (Wien). 2019; 161(2):287-306. DOI: 10.1007/s00701-018-03790-4. View